87 related articles for article (PubMed ID: 2482441)
21. Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization.
Zhou Z; Schnake P; Xiao L; Lal AA
Protein Expr Purif; 2004 Mar; 34(1):87-94. PubMed ID: 14766303
[TBL] [Abstract][Full Text] [Related]
22. [Expression in Escherichia coli of DNA coding for human tumor necrosis factor].
Dobrynin VN; Berkova NP; Boldyreva EF; Bystrov NS; Kravchenko VV
Bioorg Khim; 1988 Nov; 14(11):1530-7. PubMed ID: 3071369
[TBL] [Abstract][Full Text] [Related]
23. [Synthesis, cloning, expression and antigenicity of the therapeutic multi-epitope gene of hepatitis B virus and of its products].
Luo LM; Li M; Xia H; Huang JS; Cheng BH; Wang P
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):802-5. PubMed ID: 12919903
[TBL] [Abstract][Full Text] [Related]
24. DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence.
Fissolo N; Riedl P; Reimann J; Schirmbeck R
Eur J Immunol; 2005 Jan; 35(1):117-27. PubMed ID: 15593127
[TBL] [Abstract][Full Text] [Related]
25. [Expression of HIV-1 epitopes included in particles formed by human hepatitis B virus nucleocapsid protein].
Isaguliants MG; Kadoshnikov IuP; Kalinina TI; Khuliakov IuE; Semiletov IuA; Smirnov VD; Wahren B
Biokhimiia; 1996 Mar; 61(3):532-45. PubMed ID: 8724609
[TBL] [Abstract][Full Text] [Related]
26. Purification and structural analysis of the hepatitis B virus preS1 expressed from Escherichia coli.
Maeng CY; Oh MS; Park IH; Hong HJ
Biochem Biophys Res Commun; 2001 Apr; 282(3):787-92. PubMed ID: 11401532
[TBL] [Abstract][Full Text] [Related]
27. Plasmid vectors for the analysis of protein-induced DNA bending.
Zwieb C; Adhya S
Methods Mol Biol; 2001; 148():403-16. PubMed ID: 11357602
[No Abstract] [Full Text] [Related]
28. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
[TBL] [Abstract][Full Text] [Related]
29. [UNG-dependent correction of molecular heteroduplexes of M13 phage DNA in Escherichia coli cells].
Golubovskaia VM; Aprelikova ON; Tomilin NV
Mol Gen Mikrobiol Virusol; 1989 Jul; (7):24-9. PubMed ID: 2682222
[TBL] [Abstract][Full Text] [Related]
30. Cloning, expression and identification of the gene of human single-chain variable fragment antibody against Hepatitis B virus surface antigen.
Lun YZ; Cheng J; Zhong YW; Zhao BC
Acta Virol; 2006; 50(3):195-200. PubMed ID: 17131939
[TBL] [Abstract][Full Text] [Related]
31. Expression of hepatitis B virus large envelope protein in Escherichia coli and Saccharomyces cerevisiae.
Korec E; Korcová J; Palková Z; Vondrejs V; Korínek V; Reinis M; Bichko VV; Hlozánek I
Folia Biol (Praha); 1989; 35(5):315-27. PubMed ID: 2699291
[TBL] [Abstract][Full Text] [Related]
32. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
[TBL] [Abstract][Full Text] [Related]
34. Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common "a" determinant.
Chen WN; Oon CJ; Toh I
Am J Gastroenterol; 2000 Apr; 95(4):1098-9. PubMed ID: 10763979
[No Abstract] [Full Text] [Related]
35. Efficient production of hepatitis B surface antigen using a bovine papilloma virus-metallothionein vector.
Hsiung N; Fitts R; Wilson S; Milne A; Hamer D
J Mol Appl Genet; 1984; 2(5):497-506. PubMed ID: 6090567
[TBL] [Abstract][Full Text] [Related]
36. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia.
Carman WF; Van Deursen FJ; Mimms LT; Hardie D; Coppola R; Decker R; Sanders R
Hepatology; 1997 Dec; 26(6):1658-66. PubMed ID: 9398013
[TBL] [Abstract][Full Text] [Related]
37. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
38. Production of immunologically active surface antigens of hepatitis B virus by Escherichia coli.
MacKay P; Pasek M; Magazin M; Kovacic RT; Allet B; Stahl S; Gilbert W; Schaller H; Bruce SA; Murray K
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4510-4. PubMed ID: 6170067
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of hepatitis B surface and core antigens in E. coli.
Edman JC; Hallewell RA; Valenzuela P; Goodman HM; Rutter WJ
Nature; 1981 Jun; 291(5815):503-6. PubMed ID: 6262658
[No Abstract] [Full Text] [Related]
40. Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella.
Wu JY; Newton S; Judd A; Stocker B; Robinson WS
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4726-30. PubMed ID: 2471978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
